Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

"Locking in" a rare pathogen.

Sujata Rege1, Dipali Chavan2, Rajeev Soman3

  • 1Bharati Vidyapeeth Deemed University Medical College, Pune- Satara Road, Dhanakawadi, Pune-411043, Maharashtra, India.

Indian Journal of Medical Microbiology
|February 27, 2022
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NONTUBERCULOUS MYCOBACTERIA IN INDIA: SPECIES DISTRIBUTION AND SUSCEPTIBILITY COMPARED WITH WESTERN DATA.

Indian journal of medical microbiology·2026
Same author

Early Transition to Oral Levonadifloxacin in Two Divergent Staphylococcal Infections: Integrating Features of Levonadifloxacin and Evidence from POET and OVIVA Trials.

Microbial drug resistance (Larchmont, N.Y.)·2026
Same author

Implications of Acetylator Status and Therapeutic Drug Monitoring of Plasma Rifampicin and Isoniazid Concentrations among Indians.

The Journal of the Association of Physicians of India·2026
Same author

Why do we urgently need a new treatment for cerebral aspergillosis?

Expert review of anti-infective therapy·2026
Same author

Plazomicin in multidrug-resistant complicated urinary tract infections: a scoping review.

Therapeutic advances in infectious disease·2025
Same author

VAPA strikes the patient again!

Medical mycology case reports·2025

Escherichia hermannii is a rare cause of bloodstream infections. Antibiotic lock therapy may successfully treat catheter-related infections when catheter removal is not possible.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Nephrology

Background:

  • Escherichia hermannii, identified in 1982, is increasingly recognized as a pathogen.
  • Catheter-related bloodstream infections (CRBSI) pose significant challenges in hemodialysis patients.

Observation:

  • A hemodialysis patient developed bacteremia due to Escherichia hermannii.
  • Catheter removal is typically essential for treating such infections.

Findings:

  • Due to lack of alternative access, the hemodialysis catheter was salvaged using antibiotic lock therapy.
  • This approach proved successful in eradicating the Escherichia hermannii bacteremia.

Implications:

  • Antibiotic lock therapy is a viable treatment option for Escherichia hermannii CRBSI.
Keywords:
Antibiotic lock therapyCatheter related blood stream infectionEscherichia hermannii

Related Experiment Videos

  • This highlights a potential strategy to preserve essential hemodialysis access in challenging cases.